Buyer of a pharmaceutical company in Spain, Sweden or Switzerland

Company to buy

• Size: Small scale pharma company
• Revenue: 5-10M EUR
• Investment amount: <6M EUR
• Location of the target company: Spain, Sweden, Switzerland
• Reason for acquisition: The buyer has recognized capabilities in the formulation and EUCTD dossier standard and one Patented Product and many in the pipeline. The plan is to extend our activities as to market our products in EU market through an existing pharma set up or to buy or share an existing set up or joint venture with similar company
• #CFIE PHB01

Overview of this buyer of a pharmaceutical company in Spain, Sweden or Switzerland

Our company is a small to medium sized pharma. Manufacturer of a wide range of high-quality niche prescription drugs, OTC, Herbal & Natural medicaments, with emphasis on improved delivery system. We have good distribution channels in MENA and African countries. The R&D unit has recognized capabilities in the formulation and EUCTD dossier standard and we have one Patented Product and many in the pipeline. We acquired EU cGMP certification in 2017 with two dossiers submission in Spain. Annual revenue is around 32m Euros. Our plan is to extend our activities as to market our products in EU market through an existing pharma set up or to buy or share an existing set up or joint venture with similar company.

Profile (strategy) of this pharma manufacturer company buyer

Quality is the primary strategy for growth and development, with ISO 9001 certification as well as EU GMP. The company has been pursuing international expansion through exports to over a dozen MENA and West Africa countries and subsidiaries in two of them. Next comes market entry into the EU.

Product strategy revolves around improvement of delivery for generics in OSD, semi-solid and liquid forms. Therapeutic areas include oncology, cardiovascular, CNS, respiratory, GI, anti-infective, anti-inflammatory, anti-allergy as well a natural food supplements and a children OTC product line.

Activities and products of an ideal target pharma unit

This buyer company is looking for an acquisition of a small scale pharmaceutical formulation industry in the EU. Alternatively, the Buyer is willing to look into a joint-venture or a co-marketing deal with an established pharmaceutical manufacturer.

Target acquisition deal size could be of up to 7 million Euro. The acquisition project shall be self-funded by the company; no bank financing will be involved.

EU GMP, a good balance sheet and strong sales network are expected of the target. A focus on quality is also desirable. Product / therapeutic area complementarity will be highly valued.

Highlights of the pharma manufacturer site buye

• The buyer is a pharmaceutical company firmly established in MENA, with an ambition to expand into Europe
• The target company should be any pharmaceutical manufacturer in Spain, Sweden or Switzerland preferably
• The buyer is open to an acquisition or a joint venture as well as to co-marketing.

More information on this buyer of a pharmaceutical company in Spain, Sweden or Switzerland

Please get in touch if you are interested in learning more about this buyer of a pharmaceutical company in Spain, Sweden or Switzerland. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.